The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis

The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis

Helei Hou,* Dantong Sun,* Kewei Liu, Man Jiang, Dong Liu, Jingjuan Zhu, Na Zhou, Jing Cong, Xiaochun ZhangDepartment of Medical Oncology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, People’s Republic of China*These authors contributed equally to this workBac...

Full description

Bibliographic Details
Main Authors: Hou H, Sun D, Liu K, Jiang M, Liu D, Zhu J, Zhou N, Cong J, Zhang X
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:Cancer Management and Research
Subjects:
ALK inhibitors
adverse events
serious adverse events
lung toxicity
Online Access:https://www.dovepress.com/the-safety-and-serious-adverse-events-of-approved-alk-inhibitors-in-ma-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/the-safety-and-serious-adverse-events-of-approved-alk-inhibitors-in-ma-peer-reviewed-article-CMAR

Similar Items